LAWSON MACARTNEY

Insider Reports History

Location
La Jolla, CA
Signature
/s/ Michael Morneau, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by LAWSON MACARTNEY:

Company Role Class Num Shares Value Price $ Report Date Ownership
Viking Therapeutics, Inc. Director Common Stock, par value $0.00001 per share 51,115 $1,901,989 $37.21 02 Jan 2026 Direct
Viking Therapeutics, Inc. Director Stock Option (Right to Buy) 20,400 02 Jan 2026 Direct

Insider Reports Filed by LAWSON MACARTNEY

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VKTX Viking Therapeutics, Inc. 02 Jan 2026 2 $0 4 Director 05 Jan 2026, 20:26
VKTX Viking Therapeutics, Inc. 02 Jan 2025 1 $0 4 Director 06 Jan 2025, 20:14
VKTX Viking Therapeutics, Inc. 08 Nov 2024 3 -$125,733 4 Director 08 Nov 2024, 18:22
VKTX Viking Therapeutics, Inc. 02 Jan 2024 1 $0 4 Director 04 Jan 2024, 21:24
VKTX Viking Therapeutics, Inc. 16 May 2023 3 -$364,960 4 Director 18 May 2023, 18:30
VKTX Viking Therapeutics, Inc. 24 Apr 2023 3 -$298,781 4 Director 24 Apr 2023, 19:31
VKTX Viking Therapeutics, Inc. 17 Apr 2023 3 -$249,432 4 Director 18 Apr 2023, 19:10
VKTX Viking Therapeutics, Inc. 03 Jan 2023 1 $0 4 Director 04 Jan 2023, 17:11
VKTX Viking Therapeutics, Inc. 03 Jan 2022 1 $0 4 Director 05 Jan 2022, 18:09